Control of Reproduction in Ferrets, Rabbits and Rodents von Risi, E

Volltext

Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer:... von Malorni, L., Curigliano, G., Minisini, A.M., Cinieri, S., Tondini, C.A., D’Hollander, K., Arpino, G., Bernardo, A., Martignetti, A., Criscitiello, C., Puglisi, F., Pestrin, M., Sanna, G., Moretti, E., Risi, E., Biagioni, C., McCartney, A., Boni, L., Buyse, M., Migliaccio, I., Biganzoli, L., Di Leo, A.

Volltext

No pain, no gain… What we can learn from a trial reporting negative results von Di Leo, A., Risi, E., Biganzoli, L.

Volltext

1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab von Vaglica, M, Lambertini, M, Ferreira, A, Poggio, F, Puglisi, F, Sottotetti, F, Montemurro, F, Poletto, E, Pozzi, E, Risi, E, Lai, A, Zanardi, E, Sini, V, Ziliani, S, Minuti, G, Mura, S, Grasso, D, Ferrarini, I, Pronzato, P, Del Mastro, L

Volltext

1861 Body mass index and prognosis in HER2-positive metastatic breast cancer patients von Poletto, E, Minisini, A.M, Ferreira, A, Matteo, L, Poggio, F, Sottotetti, F, Montemurro, F, Pozzi, E, Rossi, V, Risi, E, Dellepiane, C, Sini, V, Ziliani, S, Minuti, G, Mura, S, Grasso, D, Bertolini, I, Del Mastro, L, Puglisi, F

Volltext

286TiP - Phase II randomized trial of neoadjuvant trastuzumab and pertuzumab (TP) with either palbociclib + letrozole (Pal+L) or paclitaxel (Pac) for elderly patients with estrogen... von Biganzoli, L., Brain, E., Malorni, L., Risi, E., Regan, M.M.

Volltext

Phase II randomized trial of neoadjuvant trastuzumab and pertuzumab (TP) with either palbociclib + letrozole (Pal+L) or paclitaxel (Pac) for elderly patients with estrogen receptor... von Biganzoli, L., Brain, E., Malorni, L., Risi, E., Regan, M.M.

Volltext

High-Grade Mucoepidermoid Carcinoma of the Mandibular Salivary Gland in a Lion (Panthera leo) von Dorso, L, Risi, E, Triau, S, Labrut, S, Nguyen, F, Guigand, L, Wyers, M, Abadie, J

Volltext

286TiPPhase II randomized trial of neoadjuvant trastuzumab and pertuzumab (TP) with either palbociclib + letrozole (Pal+L) or paclitaxel (Pac) for elderly patients with estrogen re... von Biganzoli, L, Brain, E, Malorni, L, Risi, E, Regan, M M

Volltext

Bactériologie des otites moyennes chez le lapin : étude rétrospective de 18 cas traités chirurgicalement von Mercado, L., Risi, E.

Volltext

2272P Minimal DNA-methylation (DNAm) signatures for non-invasive tumor-agnostic estimation of tumor content (TC) and molecular subtype in patients (pts) with metastatic breast canc... von Benelli, M., Nardone, A., Galardi, F., Romagnoli, D., De Luca, F., Gabellini, S., Paoli, M., Migliaccio, I., Pestrin, M., Sanna, G., Risi, E., Livraghi, L., Moretti, E., Biagioni, C., Malorni, L., Biganzoli, L.

Volltext

Flood risk assessment for informal settlements von De Risi, R., Jalayer, F., De Paola, F., Iervolino, I., Giugni, M., Topa, M. E., Mbuya, E., Kyessi, A., Manfredi, G., Gasparini, P.

Volltext

1883P Impact of geriatrician-implemented Interventions on chemotherapy (CT) delivery in vulnerable elderly patients with early or advanced solid tumors: The GIVE trial von Risi, E., Brunello, A., Biagioni, C., Calvani, D., Di Donato, S., Moretti, E., Bergamo, F., Pozzessere, D., Zafarana, E., Baldi, G.G., Mori, E., Palmieri, V.E., Luciani, A., Fratino, L., Del Monte, F., Malorni, L., Becheri, D., Battisti, N.M.L., Mottino, G., Biganzoli, L.

Volltext

Experimental investigation and combustion analysis of a direct injection dual-fuel diesel–natural gas engine von Carlucci, A.P., de Risi, A., Laforgia, D., Naccarato, F.

Volltext

148P Serum metabolomics based risk assessment of disease recurrence in elderly patients with early breast cancer (eBC) von Risi, E., Vignoli, A., Lisanti, C., Biagioni, C., Paderi, A., Cappadona Sciammetta, S., Del Monte, F., Moretti, E., Sanna, G., Livraghi, L., Malorni, L., Benelli, M., Puglisi, F., Luchinat, C., Tenori, L., Biganzoli, L.

Volltext

8P Mutational analysis of circulating tumour DNA (ctDNA) in patients with ER+/HER2- advanced breast cancer (ABC) receiving palbociclib (P): Results from the TREnd trial von Malorni, L., Romagnoli, D., Benelli, M., Galardi, F., Biagioni, C., Curigliano, G., Minisini, A.M., Moretti, E., Risi, E., De Luca, F., McCartney, A., Di Leo, A., Biganzoli, L., Migliaccio, I.

Volltext

6P Circulating tumour cells (CTCs) as biomarkers of resistance to the CDK4/6 inhibitor (CDK4/6i) palbociclib (P) in patients (pts) with ER+/HER2-negative advanced breast cancer (AB... von Galardi, F., Biagioni, C., De Luca, F., Curigliano, G., Minisini, A.M., Bonechi, M., Moretti, E., Risi, E., Migliaccio, I., McCartney, A., Benelli, M., Romagnoli, D., Conti, V., Biganzoli, L., Di Leo, A., Malorni, L.

Volltext

The role of abemaciclib in treatment of advanced breast cancer von McCartney, Amelia, Moretti, Erica, Sanna, Giuseppina, Pestrin, Marta, Risi, Emanuela, Malorni, Luca, Biganzoli, Laura, Di Leo, Angelo

Volltext

Synthetic Approaches to Enantiomerically Pure 8-Azabicyclo[3.2.1]octane Derivatives von Pollini, Gian P, Benetti, Simonetta, De Risi, Carmela, Zanirato, Vinicio

Volltext

Gene signatures as potential predictive markers of response to neoadjuvant chemotherapy in ER+/HER2+ breast cancer patients von Risi, E., Grilli, A., Migliaccio, I., Biagioni, C., Guarducci, C., Bonechi, M., McCartney, A., Vitale, S., Biganzoli, L., Bicciato, S., Di Leo, A., Malorni, L.

Volltext